100 Plus wins the 4th annual Living Now Awards
I’m proud to announce that 100 Plus has won the 4th annual Living Now Awards for a book on aging. http://www.independentpublisher.com/article.php?page=1577
Technology & Society
I’m proud to announce that 100 Plus has won the 4th annual Living Now Awards for a book on aging. http://www.independentpublisher.com/article.php?page=1577
Here’s a short review of 100 Plus by Jonathan Wei, a researcher who specializes in geniuses.
From Reuters: Doctors in Sweden have replaced a vital blocked blood vessel in a 10-year-old girl using the first vein grown in a lab from a patient’s own stem cells. The successful transplant operation, reported online in The Lancet medical
A good article on gene therapy from The Scientist: The concept is simple: if a mutated gene is causing a problem, replace or supplement it with a new, accurate copy. In theory, such a strategy could not just treat, but
Cancer, diabetes, Alzheimer’s — these are all diseases of aging, yet some people are willing to argue that aging is a good thing. That’s the question at hand at this Oxford University Scientific Society Debate between SENS Foundation Chief Science
Here’s a fun app from my friends over at 100Plus, the company (I’m an advisor). They are releasing this app at SXSW, but you can try it out even if you’re not attending.
Here’s a great article by Forbes columnist Bruno Aziza on big data and staying healthy. It also mentions 100Plus, a cool new company started by Chris Hogg that focuses on predicting your health. If you’re an engineer, designer, data hacker
Here’s my latest Big Think interview — this time on longevity and the family. From the transcript: “When we can live longer and healthier lives, there’s the question of what happens to many different areas of our lives. The family
The DOD is funding a lot of great work in regenerative medicine. Here’s yet another example developed at the University of Georgia’s Regenerative Bioscience Center. Thanks, DOD (and the folks over at DARPA).
Here’s a great article from PandoDaily discussing what gene sequencing companies like Halcyon might do now that another company (Oxford Nanopore) has managed to do cheap, fast, sequencing first. Halcyon board member Elon Musk has this to say: Halcyon has